Dr. Joseph Borrelli Jr., MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14555 Cortez Blvd, Brooksville, FL 34613 Phone: 352-556-4823 Fax: 352-556-4824 |
Imad Eddeen Tarabishy, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11339 Cortez Blvd, Brooksville, FL 34613 Phone: 352-596-8558 Fax: 352-596-3494 |
Dr. Steven Harding Moss, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 11373 Cortez Blvd, Suite 301, Brooksville, FL 34613 Phone: 352-597-7091 |
Dr. Avinash Laxman Jadhav, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17222 Hospital Blvd Ste 322, Brooksville, FL 34601 Phone: 352-565-5999 Fax: 352-565-4449 |
Dr. William J Jason, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 12212 Cortez Blvd, Brooksville, FL 34613 Phone: 352-683-0007 Fax: 352-556-5223 |
Dr. Terrell B Bounds, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 14540 Cortez Blvd, Suite 105, Brooksville, FL 34613 Phone: 352-596-7222 Fax: 352-596-7030 |
News Archive
The New York Times and the Financial Times examine concerns expressed by AIDS activists and members of an FDA panel that last week recommended Gilead Sciences' antiretroviral drug Truvada be approved for pre-exposure prophylaxis (PrEP) to prevent HIV among healthy people at risk of contracting the virus.
Some parts of Australia show an increase in uptake of pills that can prevent contracting HIV but also a sharp drop in condom use among men having sex with men. This was found in a major study and is cause for concern.
Exposure to chemical pollutants is of growing concern to regulators, health workers, and environmentalist groups alike. Now, researchers in the US and Russia have demonstrated that samples of human bone can act as a biological marker for dozens of metals and toxic elements across the periodic table. They describe details in a study published in the International Journal of Environment and Health.
A rule issued today by the Food and Drug Administration underscores the historical progress made towards fighting the nation's number one cause of preventable death: tobacco-related disease.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
› Verified 8 days ago